Delivery Order SPE2D018D0005-SPE2D326F1484
Award Date 11/24/25
Potential Completion Date 11/25/25
Potential Value $2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order valued at $2,074.46 by the Defense Health Agency's Medical Supply Chain on August 5, 2025, for the supply of Rh antigen anti-D blood bank reagent in 150ml monoclonal ABO group format. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Performance is scheduled for completion by August 8, 2025, at the contractor's facility in Raritan, New Jersey. This delivery order represents a...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order valued at $1,832.54 by the Defense Department's Medical Supply Chain on August 5, 2025, for the delivery of Ortho Anti-A Blood Clone 150ML Monoclonal ABO Group BB reagent. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating open competition, and is scheduled for ultimate completion by August 8, 2025. Performance will take place at the company's facility in Raritan, New Jersey....
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order valued at $3,927.36 by the Defense Health Agency's Medical Supply Chain on January 6, 2026, for the supply of Anti-A B Bioclone 10mL bottles for orthopedic blood bank applications. The contract is structured as a firm fixed-price delivery order with no set-aside designation, with performance to be completed by January 7, 2026, at the contractor's facility in Raritan, New Jersey. This award represents a task order placement under the...
- The Defense Health Agency, operating under the Defense Department's Medical Supply Chain, awarded a delivery order valued at $1,037.23 to Ortho-Clinical Diagnostics, Inc. on January 7, 2026, for Anti-D Bioclone 150ML monoclonal antibodies used in blood bank operations. The contract utilizes a firm fixed-price structure with a completion date of January 8, 2026, and was procured through open competition with no set-aside designation. Performance will occur at Ortho-Clinical Diagnostics'...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-B Bioclone 15x10ML on August 11, 2025, with completion targeted for August 14, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, headquartered in Raritan, New Jersey, is a for-profit medical equipment manufacturer specializing...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order contract on September 5, 2025, by the Defense Medical Supply Chain for the supply of Reagent Anti-D Bioclone 150mL Monoclonal with a ceiling value of $1,037.23. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and will be performed at the company's facility in Raritan, New Jersey. No set-aside designation was used for this award, indicating it was competed openly. The contract...
- The U.S. Defense Health Agency (operating under the Medical Supply Chain) awarded a fixed-price delivery order valued at $2,716.20 to Ortho-Clinical Diagnostics, Inc. for Anti-A Bioclone 150ML monoclonal antibody reagent with ABO blood group typing capabilities. This delivery order, issued December 5, 2025, with an ultimate completion date of March 2, 2026, represents a task order issued under the company's existing Indefinite Delivery Contract vehicle. The contract utilized open competition...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a delivery order valued at $5,532.10 by the Defense Health Agency's Medical Supply Chain on September 26, 2025, for a RGT Anti-D BCLN 150ML MNCLN ABO GRP BB product. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of October 1, 2025, and will be performed in Raritan, New Jersey. The award was made without a set-aside designation, indicating open competition among...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-A Bioclone 15x10ML on August 1, 2025, with an ultimate completion date of August 6, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Performance will occur at the contractor's facility in Raritan, New Jersey. Ortho-Clinical Diagnostics, Inc., a for-profit...
- Ortho-Clinical Diagnostics, Inc. has been awarded a delivery order contract by the Defense Medical Supply Chain with a ceiling value of $1,767.32 for Rght Anti-A B Bcln 10ml Btl Orth Bb—a specialized blood bank diagnostic reagent. The contract award is dated July 18, 2025, with an ultimate completion date of July 30, 2025, and will be performed at the company's facility in Raritan, New Jersey. This delivery order employs fixed-price contracting with economic price adjustment and was awarded...